|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:BRD8-HDAC3 (FusionGDB2 ID:HG10902TG8841) |
Fusion Gene Summary for BRD8-HDAC3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: BRD8-HDAC3 | Fusion gene ID: hg10902tg8841 | Hgene | Tgene | Gene symbol | BRD8 | HDAC3 | Gene ID | 10902 | 8841 |
| Gene name | bromodomain containing 8 | histone deacetylase 3 | |
| Synonyms | SMAP|SMAP2|p120 | HD3|KDAC3|RPD3|RPD3-2 | |
| Cytomap | ('BRD8')('HDAC3') 5q31.2 | 5q31.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | bromodomain-containing protein 8skeletal muscle abundant protein 2thyroid hormone receptor coactivating protein of 120 kDatrCP120 | histone deacetylase 3SMAP45 | |
| Modification date | 20200313 | 20200329 | |
| UniProtAcc | . | O15379 | |
| Ensembl transtripts involved in fusion gene | ENST00000230901, ENST00000254900, ENST00000402931, ENST00000411594, ENST00000455658, ENST00000515014, | ||
| Fusion gene scores | * DoF score | 5 X 5 X 3=75 | 3 X 3 X 3=27 |
| # samples | 5 | 3 | |
| ** MAII score | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: BRD8 [Title/Abstract] AND HDAC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | BRD8(137513260)-HDAC3(141009692), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | BRD8-HDAC3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. BRD8-HDAC3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | BRD8 | GO:0043967 | histone H4 acetylation | 14966270 |
| Hgene | BRD8 | GO:0043968 | histone H2A acetylation | 14966270 |
| Tgene | HDAC3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 16569215|18417529|18854353 |
| Tgene | HDAC3 | GO:0001934 | positive regulation of protein phosphorylation | 25190803 |
| Tgene | HDAC3 | GO:0006476 | protein deacetylation | 17172643|21030595 |
| Tgene | HDAC3 | GO:0031647 | regulation of protein stability | 25190803 |
| Tgene | HDAC3 | GO:0042307 | positive regulation of protein import into nucleus | 25190803 |
| Tgene | HDAC3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 25190803 |
| Tgene | HDAC3 | GO:0071498 | cellular response to fluid shear stress | 25190803 |
| Fusion gene breakpoints across BRD8 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across HDAC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-CD-8531-01A | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
Top |
Fusion Gene ORF analysis for BRD8-HDAC3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000230901 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| 5CDS-intron | ENST00000254900 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| 5CDS-intron | ENST00000402931 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| 5CDS-intron | ENST00000411594 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| 5CDS-intron | ENST00000455658 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| In-frame | ENST00000230901 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| In-frame | ENST00000254900 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| In-frame | ENST00000402931 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| In-frame | ENST00000411594 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| In-frame | ENST00000455658 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| intron-3CDS | ENST00000515014 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| intron-intron | ENST00000515014 | ENST00000469207 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000254900 | BRD8 | chr5 | 137513260 | - | ENST00000305264 | HDAC3 | chr5 | 141009692 | - | 2086 | 488 | 372 | 1493 | 373 |
| ENST00000230901 | BRD8 | chr5 | 137513260 | - | ENST00000305264 | HDAC3 | chr5 | 141009692 | - | 1730 | 132 | 16 | 1137 | 373 |
| ENST00000402931 | BRD8 | chr5 | 137513260 | - | ENST00000305264 | HDAC3 | chr5 | 141009692 | - | 1733 | 135 | 19 | 1140 | 373 |
| ENST00000411594 | BRD8 | chr5 | 137513260 | - | ENST00000305264 | HDAC3 | chr5 | 141009692 | - | 1769 | 171 | 55 | 1176 | 373 |
| ENST00000455658 | BRD8 | chr5 | 137513260 | - | ENST00000305264 | HDAC3 | chr5 | 141009692 | - | 1729 | 131 | 15 | 1136 | 373 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000254900 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - | 0.001120593 | 0.9988794 |
| ENST00000230901 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - | 0.001512234 | 0.9984877 |
| ENST00000402931 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - | 0.00150817 | 0.99849176 |
| ENST00000411594 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - | 0.00160637 | 0.9983936 |
| ENST00000455658 | ENST00000305264 | BRD8 | chr5 | 137513260 | - | HDAC3 | chr5 | 141009692 | - | 0.001504651 | 0.99849534 |
Top |
Fusion Genomic Features for BRD8-HDAC3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
Top |
Fusion Protein Features for BRD8-HDAC3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:137513260/chr5:141009692) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | HDAC3 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Participates in the BCL6 transcriptional repressor activity by deacetylating the H3 'Lys-27' (H3K27) on enhancer elements, antagonizing EP300 acetyltransferase activity and repressing proximal gene expression. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required to repress transcription of the POU1F1 transcription factor. Acts as a molecular chaperone for shuttling phosphorylated NR2C1 to PML bodies for sumoylation (PubMed:21444723, PubMed:23911289). Contributes, together with XBP1 isoform 1, to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to endothelial cell (EC) survival under disturbed flow/oxidative stress (PubMed:25190803). Regulates both the transcriptional activation and repression phases of the circadian clock in a deacetylase activity-independent manner (By similarity). During the activation phase, promotes the accumulation of ubiquitinated ARNTL/BMAL1 at the E-boxes and during the repression phase, blocks FBXL3-mediated CRY1/2 ubiquitination and promotes the interaction of CRY1 and ARNTL/BMAL1 (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding (PubMed:28167758). In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response (PubMed:28167758). Interacts with SETD5 (By similarity). {ECO:0000250|UniProtKB:O88895, ECO:0000269|PubMed:21444723, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:25190803, ECO:0000269|PubMed:28167758}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000230901 | - | 2 | 22 | 97_171 | 38 | 952.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000254900 | - | 2 | 27 | 97_171 | 38 | 1236.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000411594 | - | 2 | 20 | 97_171 | 38 | 867.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000230901 | - | 2 | 22 | 1120_1190 | 38 | 952.0 | Domain | Bromo 2 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000230901 | - | 2 | 22 | 724_794 | 38 | 952.0 | Domain | Bromo 1 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000254900 | - | 2 | 27 | 1120_1190 | 38 | 1236.0 | Domain | Bromo 2 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000254900 | - | 2 | 27 | 724_794 | 38 | 1236.0 | Domain | Bromo 1 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000411594 | - | 2 | 20 | 1120_1190 | 38 | 867.0 | Domain | Bromo 2 |
| Hgene | BRD8 | chr5:137513260 | chr5:141009692 | ENST00000411594 | - | 2 | 20 | 724_794 | 38 | 867.0 | Domain | Bromo 1 |
| Tgene | HDAC3 | chr5:137513260 | chr5:141009692 | ENST00000305264 | 2 | 15 | 3_316 | 93 | 429.0 | Region | Note=Histone deacetylase |
Top |
Fusion Gene Sequence for BRD8-HDAC3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >10215_10215_1_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000230901_HDAC3_chr5_141009692_ENST00000305264_length(transcript)=1730nt_BP=132nt AGACTTCGGGGCCAAGATGGCGACGGGAACGGGCAAACACAAGCTGCTAAGCACTGGCCCCACAGAGCCATGGTCCATCCGAGAGAAGCT ATGTTTAGCATCTTCTGTCATGAGAAGTGGCGATCAAAATTGCCCAGTGTTTCCCGGGCTCTTTGAGTTCTGCTCGCGTTACACAGGCGC ATCTCTGCAAGGAGCAACCCAGCTGAACAACAAGATCTGTGATATTGCCATTAACTGGGCTGGTGGTCTGCACCATGCCAAGAAGTTTGA GGCCTCTGGCTTCTGCTATGTCAACGACATTGTGATTGGCATCCTGGAGCTGCTCAAGTACCACCCTCGGGTGCTCTACATTGACATTGA CATCCACCATGGTGACGGGGTTCAAGAAGCTTTCTACCTCACTGACCGGGTCATGACGGTGTCCTTCCACAAATACGGAAATTACTTCTT CCCTGGCACAGGTGACATGTATGAAGTCGGGGCAGAGAGTGGCCGCTACTACTGTCTGAACGTGCCCCTGCGGGATGGCATTGATGACCA GAGTTACAAGCACCTTTTCCAGCCGGTTATCAACCAGGTAGTGGACTTCTACCAACCCACGTGCATTGTGCTCCAGTGTGGAGCTGACTC TCTGGGCTGTGATCGATTGGGCTGCTTTAACCTCAGCATCCGAGGGCATGGGGAATGCGTTGAATATGTCAAGAGCTTCAATATCCCTCT ACTCGTGCTGGGTGGTGGTGGTTATACTGTCCGAAATGTTGCCCGCTGCTGGACATATGAGACATCGCTGCTGGTAGAAGAGGCCATTAG TGAGGAGCTTCCCTATAGTGAATACTTCGAGTACTTTGCCCCAGACTTCACACTTCATCCAGATGTCAGCACCCGCATCGAGAATCAGAA CTCACGCCAGTATCTGGACCAGATCCGCCAGACAATCTTTGAAAACCTGAAGATGCTGAACCATGCACCTAGTGTCCAGATTCATGACGT GCCTGCAGACCTCCTGACCTATGACAGGACTGATGAGGCTGATGCAGAGGAGAGGGGTCCTGAGGAGAACTATAGCAGGCCAGAGGCACC CAATGAGTTCTATGATGGAGACCATGACAATGACAAGGAAAGCGATGTGGAGATTTAAGAGTGGCTTGGGATGCTGTGTCCCAAGGAATT TCTTTTCACCTCTTGGTTGGGCTGGAGGGAAAAGGAGTGGCTCCTAGAGTCCTGGGGGTCACCCCAGGGCTTTTGCTGACTCTGGGAAAG AGTCTGGAGACCACATTTGGTTCTCGAACCATCTACCTGCTTTTCCTCTCTCTCCCAAGGCCTGACAATGGTACCTATTAGGGATGAGAT ACAGACAAGGATAGCTATCTGGGACATTATTGGCAGTGGGCCCTGGAGGCCAGTCCCTAGCCCCCCTTGCCCCTTATTTCTTCCCTGCTT CCCTCGAACCCAGAGATTTTTGAGGGATGAACGGGTAGACAAGGACTGAGATTGCCTCTGACTTCCTCCTCCCCTGGGTTCTGACTTCTT CCTCCCCTTGCTTCCAGGGAAGATGAAGAGAGAGAGATTTGGAAGGGGCTCTGGCTCCCTAACACCTGAATCCCAGATGATGGGAAGTAT GTTTTCAAGTGTGGGGAGGATATGAAAATGTTCTGTTCTCACTTTTGGCTTTATGTCCATTTTACCACTGTTTTTATCCAATAAACTAAG >10215_10215_1_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000230901_HDAC3_chr5_141009692_ENST00000305264_length(amino acids)=373AA_BP=24 MATGTGKHKLLSTGPTEPWSIREKLCLASSVMRSGDQNCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFC YVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHL FQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPY SEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYD -------------------------------------------------------------- >10215_10215_2_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000254900_HDAC3_chr5_141009692_ENST00000305264_length(transcript)=2086nt_BP=488nt AATTCCAGTCGTTCGCTTCTGCTTGACCTCTGAGTTCTAATGTGGGTCCGGGTTACCAACTGTCGTGGATTCGCACTTATTTTGCCTGGG ATTCTTCCAACTTAACCTTTTTCCTTGAACCTTAGACATTTCTTACCTAAGAGCCTAAAGGAAATCTTGAGGCTTCAGCAGCCAACTCCT GTCCTTCCTTAGCAACAATCTTAACAGGAGTGCACAGGGTAACTGGTTTAGGGTGCTTGCTTTGTCTTAAGGGGAAAAACGACATTTCCC AGGAGGCACCGCGAACCAACGCCGGTACACTATTTCCCAGAATTCCAGGGTTTCGGCCCTTCCAGACCGTCTCTCCTCAGGGTTGGAGAC TTCGGGGCCAAGATGGCGACGGGAACGGGCAAACACAAGCTGCTAAGCACTGGCCCCACAGAGCCATGGTCCATCCGAGAGAAGCTATGT TTAGCATCTTCTGTCATGAGAAGTGGCGATCAAAATTGCCCAGTGTTTCCCGGGCTCTTTGAGTTCTGCTCGCGTTACACAGGCGCATCT CTGCAAGGAGCAACCCAGCTGAACAACAAGATCTGTGATATTGCCATTAACTGGGCTGGTGGTCTGCACCATGCCAAGAAGTTTGAGGCC TCTGGCTTCTGCTATGTCAACGACATTGTGATTGGCATCCTGGAGCTGCTCAAGTACCACCCTCGGGTGCTCTACATTGACATTGACATC CACCATGGTGACGGGGTTCAAGAAGCTTTCTACCTCACTGACCGGGTCATGACGGTGTCCTTCCACAAATACGGAAATTACTTCTTCCCT GGCACAGGTGACATGTATGAAGTCGGGGCAGAGAGTGGCCGCTACTACTGTCTGAACGTGCCCCTGCGGGATGGCATTGATGACCAGAGT TACAAGCACCTTTTCCAGCCGGTTATCAACCAGGTAGTGGACTTCTACCAACCCACGTGCATTGTGCTCCAGTGTGGAGCTGACTCTCTG GGCTGTGATCGATTGGGCTGCTTTAACCTCAGCATCCGAGGGCATGGGGAATGCGTTGAATATGTCAAGAGCTTCAATATCCCTCTACTC GTGCTGGGTGGTGGTGGTTATACTGTCCGAAATGTTGCCCGCTGCTGGACATATGAGACATCGCTGCTGGTAGAAGAGGCCATTAGTGAG GAGCTTCCCTATAGTGAATACTTCGAGTACTTTGCCCCAGACTTCACACTTCATCCAGATGTCAGCACCCGCATCGAGAATCAGAACTCA CGCCAGTATCTGGACCAGATCCGCCAGACAATCTTTGAAAACCTGAAGATGCTGAACCATGCACCTAGTGTCCAGATTCATGACGTGCCT GCAGACCTCCTGACCTATGACAGGACTGATGAGGCTGATGCAGAGGAGAGGGGTCCTGAGGAGAACTATAGCAGGCCAGAGGCACCCAAT GAGTTCTATGATGGAGACCATGACAATGACAAGGAAAGCGATGTGGAGATTTAAGAGTGGCTTGGGATGCTGTGTCCCAAGGAATTTCTT TTCACCTCTTGGTTGGGCTGGAGGGAAAAGGAGTGGCTCCTAGAGTCCTGGGGGTCACCCCAGGGCTTTTGCTGACTCTGGGAAAGAGTC TGGAGACCACATTTGGTTCTCGAACCATCTACCTGCTTTTCCTCTCTCTCCCAAGGCCTGACAATGGTACCTATTAGGGATGAGATACAG ACAAGGATAGCTATCTGGGACATTATTGGCAGTGGGCCCTGGAGGCCAGTCCCTAGCCCCCCTTGCCCCTTATTTCTTCCCTGCTTCCCT CGAACCCAGAGATTTTTGAGGGATGAACGGGTAGACAAGGACTGAGATTGCCTCTGACTTCCTCCTCCCCTGGGTTCTGACTTCTTCCTC CCCTTGCTTCCAGGGAAGATGAAGAGAGAGAGATTTGGAAGGGGCTCTGGCTCCCTAACACCTGAATCCCAGATGATGGGAAGTATGTTT TCAAGTGTGGGGAGGATATGAAAATGTTCTGTTCTCACTTTTGGCTTTATGTCCATTTTACCACTGTTTTTATCCAATAAACTAAGTCGG >10215_10215_2_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000254900_HDAC3_chr5_141009692_ENST00000305264_length(amino acids)=373AA_BP=24 MATGTGKHKLLSTGPTEPWSIREKLCLASSVMRSGDQNCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFC YVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHL FQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPY SEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYD -------------------------------------------------------------- >10215_10215_3_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000402931_HDAC3_chr5_141009692_ENST00000305264_length(transcript)=1733nt_BP=135nt TGGAGACTTCGGGGCCAAGATGGCGACGGGAACGGGCAAACACAAGCTGCTAAGCACTGGCCCCACAGAGCCATGGTCCATCCGAGAGAA GCTATGTTTAGCATCTTCTGTCATGAGAAGTGGCGATCAAAATTGCCCAGTGTTTCCCGGGCTCTTTGAGTTCTGCTCGCGTTACACAGG CGCATCTCTGCAAGGAGCAACCCAGCTGAACAACAAGATCTGTGATATTGCCATTAACTGGGCTGGTGGTCTGCACCATGCCAAGAAGTT TGAGGCCTCTGGCTTCTGCTATGTCAACGACATTGTGATTGGCATCCTGGAGCTGCTCAAGTACCACCCTCGGGTGCTCTACATTGACAT TGACATCCACCATGGTGACGGGGTTCAAGAAGCTTTCTACCTCACTGACCGGGTCATGACGGTGTCCTTCCACAAATACGGAAATTACTT CTTCCCTGGCACAGGTGACATGTATGAAGTCGGGGCAGAGAGTGGCCGCTACTACTGTCTGAACGTGCCCCTGCGGGATGGCATTGATGA CCAGAGTTACAAGCACCTTTTCCAGCCGGTTATCAACCAGGTAGTGGACTTCTACCAACCCACGTGCATTGTGCTCCAGTGTGGAGCTGA CTCTCTGGGCTGTGATCGATTGGGCTGCTTTAACCTCAGCATCCGAGGGCATGGGGAATGCGTTGAATATGTCAAGAGCTTCAATATCCC TCTACTCGTGCTGGGTGGTGGTGGTTATACTGTCCGAAATGTTGCCCGCTGCTGGACATATGAGACATCGCTGCTGGTAGAAGAGGCCAT TAGTGAGGAGCTTCCCTATAGTGAATACTTCGAGTACTTTGCCCCAGACTTCACACTTCATCCAGATGTCAGCACCCGCATCGAGAATCA GAACTCACGCCAGTATCTGGACCAGATCCGCCAGACAATCTTTGAAAACCTGAAGATGCTGAACCATGCACCTAGTGTCCAGATTCATGA CGTGCCTGCAGACCTCCTGACCTATGACAGGACTGATGAGGCTGATGCAGAGGAGAGGGGTCCTGAGGAGAACTATAGCAGGCCAGAGGC ACCCAATGAGTTCTATGATGGAGACCATGACAATGACAAGGAAAGCGATGTGGAGATTTAAGAGTGGCTTGGGATGCTGTGTCCCAAGGA ATTTCTTTTCACCTCTTGGTTGGGCTGGAGGGAAAAGGAGTGGCTCCTAGAGTCCTGGGGGTCACCCCAGGGCTTTTGCTGACTCTGGGA AAGAGTCTGGAGACCACATTTGGTTCTCGAACCATCTACCTGCTTTTCCTCTCTCTCCCAAGGCCTGACAATGGTACCTATTAGGGATGA GATACAGACAAGGATAGCTATCTGGGACATTATTGGCAGTGGGCCCTGGAGGCCAGTCCCTAGCCCCCCTTGCCCCTTATTTCTTCCCTG CTTCCCTCGAACCCAGAGATTTTTGAGGGATGAACGGGTAGACAAGGACTGAGATTGCCTCTGACTTCCTCCTCCCCTGGGTTCTGACTT CTTCCTCCCCTTGCTTCCAGGGAAGATGAAGAGAGAGAGATTTGGAAGGGGCTCTGGCTCCCTAACACCTGAATCCCAGATGATGGGAAG TATGTTTTCAAGTGTGGGGAGGATATGAAAATGTTCTGTTCTCACTTTTGGCTTTATGTCCATTTTACCACTGTTTTTATCCAATAAACT >10215_10215_3_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000402931_HDAC3_chr5_141009692_ENST00000305264_length(amino acids)=373AA_BP=24 MATGTGKHKLLSTGPTEPWSIREKLCLASSVMRSGDQNCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFC YVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHL FQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPY SEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYD -------------------------------------------------------------- >10215_10215_4_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000411594_HDAC3_chr5_141009692_ENST00000305264_length(transcript)=1769nt_BP=171nt GGGTTTCGGCCCTTCCAGACCGTCTCTCCTCAGGGTTGGAGACTTCGGGGCCAAGATGGCGACGGGAACGGGCAAACACAAGCTGCTAAG CACTGGCCCCACAGAGCCATGGTCCATCCGAGAGAAGCTATGTTTAGCATCTTCTGTCATGAGAAGTGGCGATCAAAATTGCCCAGTGTT TCCCGGGCTCTTTGAGTTCTGCTCGCGTTACACAGGCGCATCTCTGCAAGGAGCAACCCAGCTGAACAACAAGATCTGTGATATTGCCAT TAACTGGGCTGGTGGTCTGCACCATGCCAAGAAGTTTGAGGCCTCTGGCTTCTGCTATGTCAACGACATTGTGATTGGCATCCTGGAGCT GCTCAAGTACCACCCTCGGGTGCTCTACATTGACATTGACATCCACCATGGTGACGGGGTTCAAGAAGCTTTCTACCTCACTGACCGGGT CATGACGGTGTCCTTCCACAAATACGGAAATTACTTCTTCCCTGGCACAGGTGACATGTATGAAGTCGGGGCAGAGAGTGGCCGCTACTA CTGTCTGAACGTGCCCCTGCGGGATGGCATTGATGACCAGAGTTACAAGCACCTTTTCCAGCCGGTTATCAACCAGGTAGTGGACTTCTA CCAACCCACGTGCATTGTGCTCCAGTGTGGAGCTGACTCTCTGGGCTGTGATCGATTGGGCTGCTTTAACCTCAGCATCCGAGGGCATGG GGAATGCGTTGAATATGTCAAGAGCTTCAATATCCCTCTACTCGTGCTGGGTGGTGGTGGTTATACTGTCCGAAATGTTGCCCGCTGCTG GACATATGAGACATCGCTGCTGGTAGAAGAGGCCATTAGTGAGGAGCTTCCCTATAGTGAATACTTCGAGTACTTTGCCCCAGACTTCAC ACTTCATCCAGATGTCAGCACCCGCATCGAGAATCAGAACTCACGCCAGTATCTGGACCAGATCCGCCAGACAATCTTTGAAAACCTGAA GATGCTGAACCATGCACCTAGTGTCCAGATTCATGACGTGCCTGCAGACCTCCTGACCTATGACAGGACTGATGAGGCTGATGCAGAGGA GAGGGGTCCTGAGGAGAACTATAGCAGGCCAGAGGCACCCAATGAGTTCTATGATGGAGACCATGACAATGACAAGGAAAGCGATGTGGA GATTTAAGAGTGGCTTGGGATGCTGTGTCCCAAGGAATTTCTTTTCACCTCTTGGTTGGGCTGGAGGGAAAAGGAGTGGCTCCTAGAGTC CTGGGGGTCACCCCAGGGCTTTTGCTGACTCTGGGAAAGAGTCTGGAGACCACATTTGGTTCTCGAACCATCTACCTGCTTTTCCTCTCT CTCCCAAGGCCTGACAATGGTACCTATTAGGGATGAGATACAGACAAGGATAGCTATCTGGGACATTATTGGCAGTGGGCCCTGGAGGCC AGTCCCTAGCCCCCCTTGCCCCTTATTTCTTCCCTGCTTCCCTCGAACCCAGAGATTTTTGAGGGATGAACGGGTAGACAAGGACTGAGA TTGCCTCTGACTTCCTCCTCCCCTGGGTTCTGACTTCTTCCTCCCCTTGCTTCCAGGGAAGATGAAGAGAGAGAGATTTGGAAGGGGCTC TGGCTCCCTAACACCTGAATCCCAGATGATGGGAAGTATGTTTTCAAGTGTGGGGAGGATATGAAAATGTTCTGTTCTCACTTTTGGCTT >10215_10215_4_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000411594_HDAC3_chr5_141009692_ENST00000305264_length(amino acids)=373AA_BP=24 MATGTGKHKLLSTGPTEPWSIREKLCLASSVMRSGDQNCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFC YVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHL FQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPY SEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYD -------------------------------------------------------------- >10215_10215_5_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000455658_HDAC3_chr5_141009692_ENST00000305264_length(transcript)=1729nt_BP=131nt GACTTCGGGGCCAAGATGGCGACGGGAACGGGCAAACACAAGCTGCTAAGCACTGGCCCCACAGAGCCATGGTCCATCCGAGAGAAGCTA TGTTTAGCATCTTCTGTCATGAGAAGTGGCGATCAAAATTGCCCAGTGTTTCCCGGGCTCTTTGAGTTCTGCTCGCGTTACACAGGCGCA TCTCTGCAAGGAGCAACCCAGCTGAACAACAAGATCTGTGATATTGCCATTAACTGGGCTGGTGGTCTGCACCATGCCAAGAAGTTTGAG GCCTCTGGCTTCTGCTATGTCAACGACATTGTGATTGGCATCCTGGAGCTGCTCAAGTACCACCCTCGGGTGCTCTACATTGACATTGAC ATCCACCATGGTGACGGGGTTCAAGAAGCTTTCTACCTCACTGACCGGGTCATGACGGTGTCCTTCCACAAATACGGAAATTACTTCTTC CCTGGCACAGGTGACATGTATGAAGTCGGGGCAGAGAGTGGCCGCTACTACTGTCTGAACGTGCCCCTGCGGGATGGCATTGATGACCAG AGTTACAAGCACCTTTTCCAGCCGGTTATCAACCAGGTAGTGGACTTCTACCAACCCACGTGCATTGTGCTCCAGTGTGGAGCTGACTCT CTGGGCTGTGATCGATTGGGCTGCTTTAACCTCAGCATCCGAGGGCATGGGGAATGCGTTGAATATGTCAAGAGCTTCAATATCCCTCTA CTCGTGCTGGGTGGTGGTGGTTATACTGTCCGAAATGTTGCCCGCTGCTGGACATATGAGACATCGCTGCTGGTAGAAGAGGCCATTAGT GAGGAGCTTCCCTATAGTGAATACTTCGAGTACTTTGCCCCAGACTTCACACTTCATCCAGATGTCAGCACCCGCATCGAGAATCAGAAC TCACGCCAGTATCTGGACCAGATCCGCCAGACAATCTTTGAAAACCTGAAGATGCTGAACCATGCACCTAGTGTCCAGATTCATGACGTG CCTGCAGACCTCCTGACCTATGACAGGACTGATGAGGCTGATGCAGAGGAGAGGGGTCCTGAGGAGAACTATAGCAGGCCAGAGGCACCC AATGAGTTCTATGATGGAGACCATGACAATGACAAGGAAAGCGATGTGGAGATTTAAGAGTGGCTTGGGATGCTGTGTCCCAAGGAATTT CTTTTCACCTCTTGGTTGGGCTGGAGGGAAAAGGAGTGGCTCCTAGAGTCCTGGGGGTCACCCCAGGGCTTTTGCTGACTCTGGGAAAGA GTCTGGAGACCACATTTGGTTCTCGAACCATCTACCTGCTTTTCCTCTCTCTCCCAAGGCCTGACAATGGTACCTATTAGGGATGAGATA CAGACAAGGATAGCTATCTGGGACATTATTGGCAGTGGGCCCTGGAGGCCAGTCCCTAGCCCCCCTTGCCCCTTATTTCTTCCCTGCTTC CCTCGAACCCAGAGATTTTTGAGGGATGAACGGGTAGACAAGGACTGAGATTGCCTCTGACTTCCTCCTCCCCTGGGTTCTGACTTCTTC CTCCCCTTGCTTCCAGGGAAGATGAAGAGAGAGAGATTTGGAAGGGGCTCTGGCTCCCTAACACCTGAATCCCAGATGATGGGAAGTATG TTTTCAAGTGTGGGGAGGATATGAAAATGTTCTGTTCTCACTTTTGGCTTTATGTCCATTTTACCACTGTTTTTATCCAATAAACTAAGT >10215_10215_5_BRD8-HDAC3_BRD8_chr5_137513260_ENST00000455658_HDAC3_chr5_141009692_ENST00000305264_length(amino acids)=373AA_BP=24 MATGTGKHKLLSTGPTEPWSIREKLCLASSVMRSGDQNCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFC YVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHL FQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPY SEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BRD8-HDAC3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BRD8-HDAC3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | HDAC3 | O15379 | DB02546 | Vorinostat | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for BRD8-HDAC3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | BRD8 | C0014175 | Endometriosis | 1 | CTD_human |
| Hgene | BRD8 | C0269102 | Endometrioma | 1 | CTD_human |
| Tgene | C0036341 | Schizophrenia | 4 | PSYGENET | |
| Tgene | C0018799 | Heart Diseases | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies